
Remedium Lifecare Ltd is Rated Strong Sell
2026-01-30 10:11:02Remedium Lifecare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 16 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below are based on the company’s current position as of 30 January 2026, providing investors with the latest perspective on its performance and prospects.
Read full news article
Remedium Lifecare Ltd is Rated Strong Sell
2026-01-19 10:10:32Remedium Lifecare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 16 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below are based on the company’s current position as of 19 January 2026, providing investors with the latest insights into its performance and prospects.
Read full news article
Remedium Lifecare Ltd is Rated Strong Sell
2026-01-07 10:10:39Remedium Lifecare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 16 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 07 January 2026, providing investors with the most recent and relevant data to understand the stock’s standing today.
Read full news article
Remedium Lifecare Ltd Stock Hits 52-Week Low Amid Continued Downtrend
2026-01-02 13:00:39Remedium Lifecare Ltd’s shares touched a fresh 52-week low of Rs.0.7 on 2 Jan 2026, marking a significant decline amid persistent negative financial performance and weakening market sentiment within the Trading & Distributors sector.
Read full news article
Remedium Lifecare Ltd Falls to 52-Week Low Amid Continued Financial Struggles
2026-01-01 16:07:04Remedium Lifecare Ltd, a company operating in the Trading & Distributors sector, has reached a new 52-week and all-time low of Rs.0.74 today, marking a significant decline in its stock price amid ongoing financial difficulties and subdued market performance.
Read full news article
Remedium Lifecare Ltd Falls to 52-Week Low Amidst Continued Downtrend
2025-12-31 14:53:13Remedium Lifecare Ltd’s shares touched a new 52-week low of Rs.0.76 today, marking a significant decline amid persistent negative financial performance and weak market positioning within the Trading & Distributors sector.
Read full news article
Remedium Lifecare Stock Falls to 52-Week Low of Rs.0.79 Amid Continued Downtrend
2025-12-26 10:44:06Remedium Lifecare has reached a new 52-week low of Rs.0.79, marking a significant decline in its stock price amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance and market positioning.
Read full news article
Remedium Lifecare Ltd is Rated Strong Sell
2025-12-25 15:12:53Remedium Lifecare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 16 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are based on the company’s current position as of 25 December 2025, providing investors with the latest comprehensive analysis.
Read full news article
Remedium Life Sees Revision in Market Evaluation Amid Challenging Financial Trends
2025-12-06 10:10:23Remedium Life, a microcap player in the Trading & Distributors sector, has undergone a notable revision in its market evaluation metrics, reflecting ongoing challenges in its financial and operational performance. This shift highlights the company’s current standing amid a difficult market environment and persistent negative trends across key financial parameters.
Read full news articleBoard Meeting Intimation for Consider Un-Audited Financial Results/Statements (Standalone & Consolidated) Of The Company For The Third Quarter And Nine Months Ended December 31 2025
03-Feb-2026 | Source : BSESupha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve Un-Audited Financial Results/Statements (Standalone & Consolidated) of the Company for the Third Quarter and Nine months ended December 31 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
20-Jan-2026 | Source : BSESubmission of Reg. 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31.12.2025
Closure of Trading Window
22-Dec-2025 | Source : BSEIntimation of closure of Trading Window
Corporate Actions
14 Feb 2026
No Dividend history available
Remedium Lifecare Ltd has announced 1:5 stock split, ex-date: 23 Feb 24
Remedium Lifecare Ltd has announced 3:1 bonus issue, ex-date: 05 Jul 24
Remedium Lifecare Ltd has announced 61:50 rights issue, ex-date: 15 Apr 25






